Argent BioPharma secures A$11m facility to complete AusCann acquisition by Adam Sheldon November 17, 2025November 17, 2025 Argent BioPharma has secured an A$11 million funding facility to complete its acquisition of AusCann Group […]
Argent BioPharma inks deal to acquire AusCann assets and IP by Martin Lane August 19, 2025August 21, 2025
Argent Biopharma and Auscann sign deal to ‘enhance drug development’ by Steve Jones April 23, 2025April 23, 2025
